Velarion Records
Free. Unsubscribe any time.

Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics, Inc. filed 24 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 87 transactions and 422,697 shares. None carries the SEC's AFF10B5ONE flag; all 24 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Oruka Therapeutics, Inc. 87

Adoption dates in Oruka Therapeutics, Inc. 5

Results prints in Oruka Therapeutics, Inc. 0

Trades before a print in Oruka Therapeutics, Inc. 0

Interval to Oruka Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Oruka Therapeutics, Inc. states

Filing text: “10b5-1 trading plan entered into on September 19, 2025”

Sources: SEC EDGAR full-text search and the SEC submissions API.